Axsome Therapeutics, Inc.
AXSM
33 insider filings · Latest: Jul 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Jul 1 11:30 PM | TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner | Sale | 49,666 | $240.25 | $11.9M | 7,229(D) | View → |
| Jul 1, 2026 | Jul 1 9:35 PM | Herriot Tabuteau | Proposed Sale | 49,666 | $240.66 | $12.0M | — | View → |
| Jun 11, 2026 | Jun 12 12:34 AM | Roger JeffsDirector | Sale | 286 | $249.12 | $71.2K | 58,367(D) | View → |
| Jun 10, 2026 | Jun 12 12:34 AM | Roger JeffsDirector | Sale | 286 | $246.18 | $70.4K | 58,653(D) | View → |
| Jun 11, 2026 | Jun 11 9:09 PM | JEFFS ROGER | Proposed Sale | 286 | $249.12 | $71.2K | — | View → |
| Jun 10, 2026 | Jun 11 1:49 AM | Susan MahonyDirector | Sale | 300 | $246.18 | $73.9K | 829(D) | View → |
| Jun 9, 2026 | Jun 11 1:49 AM | Susan MahonyDirector | Sale | 300 | $237.21 | $71.2K | 1,129(D) | View → |
| Jun 10, 2026 | Jun 11 1:49 AM | Mark ColemanDirector | Sale | 643 | $249.00 | $160.1K | 30,389(D) | View → |
| Jun 10, 2026 | Jun 10 8:17 PM | Mahony Susan | Proposed Sale | 300 | $246.18 | $73.9K | — | View → |
| Jun 10, 2026 | Jun 10 8:16 PM | JEFFS ROGER | Proposed Sale | 286 | $246.18 | $70.4K | — | View → |
| Jun 10, 2026 | Jun 10 8:15 PM | Coleman Mark | Proposed Sale | 643 | $249.00 | $160.1K | — | View → |
| Jun 9, 2026 | Jun 9 10:01 PM | Herriot Tabuteau | Proposed Sale | 49,670 | $245.64 | $12.2M | — | View → |
| Jun 9, 2026 | Jun 9 9:17 PM | TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner | Sale | 49,670 | $241.01 | $12.0M | 7,229(D) | View → |
| Jun 9, 2026 | Jun 9 9:17 PM | Nick PizzieChief Financial Officer | Sale | 33,000 | $240.09 | $7.9M | 42,867(D) | View → |
| Jun 9, 2026 | Jun 9 8:09 PM | Pizzie Nick | Proposed Sale | 33,000 | $240.09 | $7.9M | — | View → |
| Jun 9, 2026 | Jun 9 8:06 PM | Mahony Susan | Proposed Sale | 300 | $237.21 | $71.2K | — | View → |
| Jun 2, 2026 | Jun 2 11:00 PM | Mark ColemanDirector | Sale | 5,537 | $223.39 | $1.2M | 29,603(D) | View → |
| Jun 1, 2026 | Jun 2 11:00 PM | Mark ColemanDirector | Sale | 6,000 | $230.30 | $1.4M | 35,140(D) | View → |
| May 29, 2026 | Jun 2 11:00 PM | Mark ColemanDirector | Sale | 6,000 | $233.46 | $1.4M | 41,140(D) | View → |
| Jun 2, 2026 | Jun 2 8:10 PM | Coleman Mark | Proposed Sale | 5,537 | $223.39 | $1.2M | — | View → |
Page 1 of 4
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Feb 28 12:10 AM | Nick PizzieChief Financial Officer | Grant/Award | 18,570 | — | 18,570(D) | View → |
| Feb 26, 2026 | Feb 28 12:10 AM | Hunter R. MurdockGeneral Counsel | Grant/Award | 16,385 | — | 16,385(D) | View → |
| Feb 26, 2026 | Feb 28 12:10 AM | Ari MaizelChief Commercial Officer | Grant/Award | 16,385 | — | 16,385(D) | View → |
| Feb 26, 2026 | Feb 28 12:10 AM | Mark L. JacobsonChief Operating Officer | Grant/Award | 19,663 | — | 19,663(D) | View → |
| Feb 26, 2026 | Feb 28 12:00 AM | Mark L. JacobsonChief Operating Officer | Option Exercise | 35,378 | $2.85 | 0(D) | View → |
| Feb 23, 2026 | Feb 26 12:00 AM | Mark ColemanDirector | Option Exercise | 6,250 | $4.95 | 7,721(D) | View → |
| Feb 20, 2026 | Feb 24 12:23 AM | Mark ColemanDirector | Option Exercise | 12,485 | $4.95 | 13,971(D) | View → |
| Feb 10, 2026 | Feb 11 12:11 AM | Mark ColemanDirector | Option Exercise | 5,193 | $8.02 | 0(D) | View → |
| Feb 2, 2026 | Feb 2 11:30 PM | TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner | Option Exercise | 32,410 | $185.60 | 0(D) | View → |
| Jan 22, 2026 | Jan 24 12:00 AM | Nick PizzieChief Financial Officer | Option Exercise | 12,000 | $3.50 | 105,000(D) | View → |
| Jan 21, 2026 | Jan 24 12:00 AM | Ari MaizelChief Commercial Officer | Option Exercise | 7,500 | $70.73 | 31,210(D) | View → |
← Previous
Page 2 of 2